Show simple item record

dc.contributor.authorDivband, B
dc.contributor.authorRashidi, MR
dc.contributor.authorKhatamian, M
dc.contributor.authorEslamian, GRK
dc.contributor.authorGharehaghaji, N
dc.contributor.authorTabriz, FD
dc.date.accessioned2018-08-26T07:13:10Z
dc.date.available2018-08-26T07:13:10Z
dc.date.issued2018
dc.identifier10.1515/chem-2018-0001
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44899
dc.description.abstractDifferent cation-exchanged (K+, Na+ & Ca2+) nano-zeolites with magnetite nanocomposites were synthesized and their suitability for drug loading was studied. Nanocomposites with different Fe3O4 contents were synthesized by adding magnetic Fe3O4 nanoparticles to the zeolite crystallization solution. The zeolite and its nanocomposites had high surface areas and enough adsorption capacity to load and release sufficient amounts of the chemotherapeutic doxorubicin. None of the zeolites or nanocomposites showed toxicity to SKBr3 or MCF-7 cancer cells. However, DOX@zeolite inhibits cell growth more than the non-encapsulated drug. Thus zeolites and their magnetite nanocomposites show potential as biocompatible medical devices.
dc.language.isoEnglish
dc.relation.ispartofOPEN CHEMISTRY
dc.subjectNano magnetite zeolite
dc.subjectdoxorubicin
dc.subjectdrug loading capacity
dc.subjectcytocompatibility
dc.titleLinde Type A and nano magnetite/NaA zeolites: cytotoxicity and doxorubicin loading efficiency
dc.typeArticle
dc.citation.volume16
dc.citation.issue1
dc.citation.spage21
dc.citation.epage28
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1515/chem-2018-0001


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record